(Total Views: 455)
Posted On: 08/06/2019 6:50:45 PM
Post# of 154912
Not quite THE MOMENT, but close. The treatment of this patient will hopefully prove the mechanism of action demonstrated in the mice, but the patient is not part of the phase 2 trial.
NP didn’t get into specifics, but it looks like new cancer Doc is moving forward with the phase 2 mTNBC trial. Hopefully this patients CTC at 21 days shows a decrease and that will help fill up the phase 2 trial.
NP didn’t get into specifics, but it looks like new cancer Doc is moving forward with the phase 2 mTNBC trial. Hopefully this patients CTC at 21 days shows a decrease and that will help fill up the phase 2 trial.
(0)
(0)
